Johnson & Johnson (JNJ) Earnings Prove The Free Cash Is Flowing

Schwab Network

English - April 19, 2023 14:39 - 5 minutes - 60.3 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Bluerock Capital Markets CEO On Opportunities In Real Estate

Next Episode: Embracing Gig Workers Leads To Innovation & Diverse Pool Of Talent

Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.